ALICIA EMERY: Open Payments
NPI 1114419728 · WEAVERVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 11 payments from 6 companies in 2025. Trend: 2023 $434 · 2024 $278 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Neurocrine BioSciences, Inc. | 3 | $119 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
Products named: ABILIFY MAINTENA, NUPLAZID, COBENFY, INGREZZA, AUSTEDO XR, HETLIOZ, FANAPT.
Industry payments across NC — which companies pay providers there.
